FDA’s Division of Anti-Viral Drugs
Executive Summary
Director Ellen Cooper, MD, has asked to be reassigned to some other review section with the agency. FDA said that Cooper has expressed frustration with her job. Cooper became the director when the unit was established in March 1988.